RxDoctor Payments Data

Jason Odell, MD

Foot and Ankle Surgery · Florence, SCNPI 1174733125

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (40.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Medline Industries LP accounts for 89.4% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $15,890, more than ten times the $1,503 reported in 2019.

$45,862in general payments, 2019–2025

Across 101 payments — averaging $454.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medline Industries LP$41K
  • Medshape, Inc.$2K
  • Smith+Nephew$1K
  • Johnson & Johnson$274
  • Peerless Surgical Inc.$260
  • Bsn Medical Inc$217
  • plus $781 from 19 others

What the payments were for

  • Royalty or licence$18,65441%
  • Consulting fees$12,35027%
  • Speaking & faculty fees$7,02215%
  • Travel & lodging$4,45510%
  • Food & beverage$3,3817%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,862 in reported general payments places this provider in the 85th percentile of 87 foot and ankle surgery providers in South Carolina.

See all foot and ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$216,062
Medicare patients
467
Services billed
7,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin66$510
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen51$455
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$452
Cephalexin25$151
Tramadol Hcl18$47
Carisoprodol13$46
Meloxicam11$43

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →